What was the overall market valuation of the US eye melanoma market in 2024?

The overall market valuation was $1211.78 Million in 2024. Read More

What is the projected market valuation for the US eye melanoma market by 2035?

The projected valuation for 2035 is $2513.18 Million. Read More

What is the expected CAGR for the US eye melanoma market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 6.86%. Read More

Which companies are considered key players in the US eye melanoma market?

Key players include Novartis, Bristol-Myers Squibb, Merck & Co, Amgen, Regeneron Pharmaceuticals, Genentech, Pfizer, and Eisai. Read More

What are the segment valuations for the treatment of eye melanoma?

Segment valuations for treatment include $500.0 Million for surgery, $300.0 Million for radiation therapy, and $250.0 Million for laser treatment. Read More

How does the market valuation for the retina segment compare to the uvea segment?

The retina segment was valued at $363.54 Million, whereas the uvea segment was valued at $484.72 Million. Read More

What is the valuation range for biopsy as a diagnostic method in the US eye melanoma market?

The valuation range for biopsy as a diagnostic method is $400.0 Million to $800.0 Million. Read More

What are the projected valuations for hospitals and clinics as end users in the market?

Projected valuations for hospitals and clinics as end users range from $726.71 Million to $1510.12 Million. Read More

What is the valuation range for imaging as a diagnostic method in the US eye melanoma market?

The valuation range for imaging as a diagnostic method is $300.0 Million to $600.0 Million. Read More

What are the projected valuations for the 'others' category in the treatment segment?

The projected valuations for the 'others' category in the treatment segment range from $161.78 Million to $413.18 Million. Read More

US Eye Melanoma Market

ID: MRFR/MED/18093-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Eye Melanoma Market Research Report By Site (Sclera, Retina, Uvea) and By Diagnosis (Eye Exam, Imaging, Biopsy) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Site (USD Million)
  1. 4.1.1 sclera
  2. 4.1.2 retina
  3. 4.1.3 uvea
  4. 4.1.4 others
2. 4.2 Medical Device, BY Diagnosis (USD Million)
  1. 4.2.1 eye exam
  2. 4.2.2 imaging
  3. 4.2.3 biopsy
  4. 4.2.4 others
3. 4.3 Medical Device, BY Treatment (USD Million)
  1. 4.3.1 radiation therapy
  2. 4.3.2 laser treatment
  3. 4.3.3 surgery
  4. 4.3.4 others
4. 4.4 Medical Device, BY End User (USD Million)
  1. 4.4.1 hospitals & clinics
  2. 4.4.2 academic institutes
  3. 4.4.3 others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Novartis (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bristol-Myers Squibb (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Merck & Co (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Amgen (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Regeneron Pharmaceuticals (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Genentech (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Pfizer (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eisai (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY SITE
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 US MARKET ANALYSIS BY TREATMENT
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY SITE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY SITE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SITE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Site (USD Million, 2025-2035)

sclera
retina
uvea
others

Medical Device By Diagnosis (USD Million, 2025-2035)

eye exam
imaging
biopsy
others

Medical Device By Treatment (USD Million, 2025-2035)

radiation therapy
laser treatment
surgery
others

Medical Device By End User (USD Million, 2025-2035)

hospitals & clinics
academic institutes
others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”